<http://schema.org/headline>
"Aeterna Zentaris Granted Special Protocol Assessment by the FDA for Phase 3 Registration Trial in Endometrial Cancer with AEZS-108"^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fiercebiotech.com/press-releases/aeterna-zentaris-granted-special-protocol-assessment-fda-phase-3-registrati>